跳至主要内容
临床试验/NCT04318769
NCT04318769进行中(未招募)不适用

An Affirmative Coping Skills Intervention to Improve Mental and Sexual Health of Sexual and Gender Minority Youth (AFFIRM): A Stepped Wedge Waitlist Crossover Trial

University of Toronto7 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2017年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
300
试验地点
7
主要终点
Acceptability - participant satisfaction with group sessions

研究概览

简要总结

AFFIRM is an 8-session manualized group coping skills intervention focused on reducing sexual risk behaviours and psychosocial distress among SGMY. AFFIRM is delivered by two facilitators (primarily social workers and peers) through a combination of education and rehearsal (i.e., simulation of real-life experiences) in a manner that affirms participants' sexual and gender minority identities and experiences. AFFIRM is being tested in a five-year trial using a stepped wedge waitlist crossover design, where all participants receive the intervention in clusters.

详细描述

Session 1 focus

Introduction to cognitive behavioral therapy (CBT), exploring lesbian, gay, bisexual, transgender, and queer (LGBTQ)+ identities, and understanding minority stress.

Session 1 activities

Introductions

Discussing the theory and purpose of CBT approaches

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
Double (Care Provider, Outcomes Assessor)

盲法说明

Participants are not blinded as they know which arm they are allocated too. Care providers and outcome assessors are blinded as the investigator runs the allocation sequence and outcomes are administered via survey weblink

入排标准

年龄范围
14 Years 至 29 Years(Child, Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Aged 14 to 29 years at time of screening
  • •Identifies as a sexual and/or gender minority
  • •Reads, writes, and speaks fluent English
  • •Is interested in participating in the 8-session AFFIRM intervention

排除标准

  • •Assessed to be in crisis (i.e., high risk of suicidality)
  • •Warrenting a more intensive intervention

研究组 & 干预措施

AFFIRM

Experimental

AFFIRM is an 8-session psychoeducational weekly group intervention

干预措施: AFFIRM (Behavioral)

Waitlisted control

No Intervention

Waitlisted control

结局指标

主要结局

Acceptability - participant satisfaction with group sessions

时间窗: week 56

Participants will complete a satisfaction questionnaire.

Feasibility - participant attendance at group sessions

时间窗: week 56

Proportions of participants that enroll, commence, and complete the intervention.

次要结局

  • Intervention fidelity - how closely facilitators adhere to intervention model(Study period sessions 1-8 (weeks 1-8))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shelley Craig

Professor

University of Toronto

研究点 (7)

Loading locations...

相似试验

已完成
不适用
Multicomponent Intervention to Reduce Sexual Risk and Substance UseSexually Transmitted InfectionsSubstance UseHIV
NCT01880489Hunter College of City University of New York143
已完成
不适用
An Emotion Regulation Intervention for Early Adolescent Risk PreventionRisk BehaviorRisk ReductionEmotion Regulation
NCT03430570Rhode Island Hospital85
已完成
不适用
A Behavioral Intervention to Reduce Sexual Risk Among African-American Men Who Have Sex With MenHIV Infections
NCT00691496Centers for Disease Control and Prevention326
已完成
2 期
Maintaining HIV Prevention Gains in Female AdolescentsHIV InfectionSexually Transmitted Diseases
NCT00161343University of Rochester640
已完成
不适用
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their PartnersMalignant Female Reproductive System NeoplasmStage IIIA Breast CancerStage IIIA Colorectal CancerStage IIIC Skin MelanomaStage IV Lung CancerMalignant Hepatobiliary NeoplasmStage III Colorectal CancerStage IIIA Cervical CancerStage IVA Uterine Corpus CancerStage IVB Cervical CancerStage IVB Colorectal CancerStage III Cervical CancerStage IIIA Uterine Corpus CancerStage IIIB Breast CancerStage IIIB Colorectal CancerStage IIIB Lung CarcinomaStage IIIB Skin MelanomaStage IVB Uterine Corpus CancerPartnerStage III Breast CancerStage III Lung CancerStage III Uterine Corpus CancerStage IIIC Breast CancerStage IIIC Colorectal CancerStage IIIC Uterine Corpus CancerStage IV Cervical CancerStage IV Prostate CancerStage IV Uterine Corpus CancerStage III Prostate CancerStage III Skin MelanomaStage IIIA Lung CarcinomaStage IIIA Skin MelanomaStage IIIB Cervical CancerStage IIIB Uterine Corpus CancerStage IV Breast CancerStage IV Colorectal CancerStage IV Skin MelanomaStage IVA Cervical CancerStage IVA Colorectal Cancer
NCT03112668Rutgers, The State University of New Jersey14